Price variability of TNF-α inhibitor biosimilars among European countries

J Eur Acad Dermatol Venereol. 2024 Aug;38(8):e663-e665. doi: 10.1111/jdv.19756. Epub 2023 Dec 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / economics
  • Adalimumab / therapeutic use
  • Biosimilar Pharmaceuticals* / economics
  • Biosimilar Pharmaceuticals* / therapeutic use
  • Drug Costs
  • Europe
  • Humans
  • Infliximab / economics
  • Infliximab / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Biosimilar Pharmaceuticals
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab